February 18, 2022 February 18, 2022Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US
February 17, 2022 February 17, 2022Confluent Medical Announces Closing of Majority Investment From TPG
January 12, 2022 January 12, 2022Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene
November 22, 2021 November 22, 2021ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
